ESC2025 Premium Access

Efficacy, safety, and medical resource use of intensive blood pressure control in subgroups of hypertension duration and baseline systolic blood pressure level: results from the ESPRIT trial

Congress Presentation

About the speaker

Miss Yue Peng

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)
0 follower

4 more presentations in this session

Impact of zilebesiran, an investigational RNA interference therapeutic targeting hepatic angiotensinogen, on renin-angiotensin system biomarkers in patients with mild-to-moderate hypertension

Speaker: Doctor M. Weber (Brooklyn, US)

Thumbnail

Efficacy and safety of low-dose antihypertensive combination drugs including amlodipine, telmisartan, and chlorthalidone: a multicenter, randomized, double-blinded, parallel, phase III clinical trial

Speaker: Professor C. Park (Seoul, KR)

Thumbnail

Single-pill low-dose triple combination therapy versus standard-dose monotherapy in patients with mild to moderate hypertension: results from two randomized clinical trials

Speaker: Professor M. Rhee (Goyang, KR)

Thumbnail

Associations of coronary, cerebrovascular and peripheral vascular events with individual components of blood pressure among hypertensive adults: comparing relationships in ASCOT, ALLHAT and SPRINT

Speaker: Doctor A. Ahmed (London, GB) Associate Professor A. Gupta (London, GB)

Thumbnail

Access the full session

Treatment of hypertension: randomised controlled trials

Speakers: Miss Y. Peng, Doctor M. Weber, Professor C. Park, Professor M. Rhee, Doctor A. Ahmed...
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations